Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGS of Urinary Bacteria in Low Colony Count UTI
NCT05206500Phase 4Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2022
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in urinary tract infection (UTI), sponsored by Wake Forest University Health Sciences. Primary endpoint: Next Generation Sequencing Results (Colony Count) at 3 weeks. Started May 2022; status: recruiting.
02
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT05206500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05206500.